Pnc Financial Services Group, Inc. Gilead Sciences, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 420,970 shares of GILD stock, worth $52.2 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
420,970
Previous 416,136
1.16%
Holding current value
$52.2 Million
Previous $46.1 Million
1.28%
% of portfolio
0.03%
Previous 0.03%
Shares
33 transactions
Others Institutions Holding GILD
# of Institutions
2,408Shares Held
1.01BCall Options Held
8.51MPut Options Held
7.32M-
Vanguard Group Inc Valley Forge, PA121MShares$15 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...